SIDE EFFECTS: The most common side effects associated with ipratropium are:
GENERIC AVAILABLE: Yes
PREPARATIONS: Nasal Inhaler: 0.03 or 0.06%. Oral Inhaler (aerosol): 0.021 mg/spray
STORAGE: Ipratropium should be kept at room temperature, 15 C-30 C (59 F-86 F). Excessive humidity should be avoided.
- The recommended dose for allergies is 2 sprays (0.03%) in each nostril 2 or 3 times daily.
- The dose for treating symptoms of the common cold is 2 sprays (0.06%) in each nostril 3 to 4 times daily.
- The dose for treating asthma is 8 inhalations every 20 minutes as needed for up to 3 hours.
- The dose for treating bronchospasms associated with COPD is 2 puffs 4 times daily and additional puffs if needed but not to exceed 12 puffs per day.
PREGNANCY: Studies of ipratropium in animals have not demonstrated negative effects on the fetus. There have been no studies in humans.
NURSING MOTHERS: It is not known if ipratropium is secreted in breast milk. Other medications in the same class of drugs are secreted into breast milk. It is not known whether the small amounts that may appear in the milk are of any consequence to the infant.
Reference: FDA Prescribing Information
Quick GuideCOPD Lung Symptoms, Diagnosis, Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.